Search





Search





Spruce Biosciences On March 16, Entered Termination Agreement With Kaken Pharmaceutical - SEC Filing

ReutersMar 20, 2026 9:42 PM

March 20 (Reuters) - SEC Filing:

SPRUCE BIOSCIENCES INC - ON MARCH 16, ENTERED TERMINATION AGREEMENT WITH KAKEN PHARMACEUTICAL - SEC FILING
SPRUCE BIOSCIENCES INC - COLLABORATION AGREEMENT WITH KAKEN PHARMACEUTICAL TO TERMINATE EFFECTIVE MARCH 31, 2026 - SEC FILING
SPRUCE BIOSCIENCES INC - ALL LICENSES & RIGHTS GRANTED BY CO TO KAKEN TO BE TERMINATDE; NO UNEARNED MILESTONE PAYMENTS OR ROYALTIES

Source text: [ID:n0001193125-26-117888]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Trump Withdrawal Intent Reshapes Liquidity, Bitcoin Breaks $68,000 Mark

As the U.S. and Iran signal potential ceasefire negotiations, Bitcoin surged past $68,000, with a continued short-term rally expected.

Micron Stock Gains 5% as Google’s TurboQuant Sparks 20% Valuation Gap, Eyeing Semiconductor Rally Revival

TradingKey - During the U.S. trading session on March 31, Micron staged a strong rebound, closing up 4.98%. This performance may boost investor confidence following the recent collective correction in memory stocks. Beyond Micron, the semiconductor sector saw broad gains: SanDisk (SNDK) closed up 10

Buffett Admits Selling Apple Early, Can Apple Stock Price Still Rise? Need to Watch These Three Signals

TradingKey — Warren Buffett admitted that trimming his stake in Apple was premature. This statement garnered market attention not only because gains have exceeded $100 billion, but more importantly, because it highlights a more practical issue: once a company becomes sufficiently successful and mass

What Is Palantir? Can Palantir’s Stock Price Return to $200 in 2026?

TradingKey - In today’s highly competitive technology landscape, Palantir (PLTR), as a company with a core focus on big data and artificial intelligence, has garnered widespread attention through its unique technological advantages and market positioning.

Bitcoin Price Analysis: What Is to Stop BTC from Making Another Run at All-Time Highs in 2026?

This strategic analysis covers institutional BTC price targets from JPMorgan and Fidelity, the impact of the U.S. Strategic Reserve, and whether the four-year cycle is broken. Stay updated on BTC to USD trends and key market risks.

Tradingkey

KeyAI

